Experts at Texas Heart Institute and Baylor St. Luke’s Medical Center have earned a prestigious American College of Cardiology accreditation as a transcatheter aortic valve replacement (TAVR) Center of Excellence, the only program in Houston to be recognized for this level of quality and clinical outcomes.
“This distinction underscores our commitment to excellence and the treatment of complex cardiovascular patients,” said Texas Heart Institute’s Dr. Stephanie Coulter.
The comprehensive external review and certification process acknowledges the highest standards for training, team-based care, patient-focused decision-making, and clinical performance. The designation also requires participation in a TAVR national clinical database to achieve certification.
Centers that achieve ACC Transcatheter Valve Certification follow best practices for using evidence-based medicine to support decision-making in the care of individual patients.
“We are proud of this designation. It validates the expertise of our team, the patient care processes we have implemented, our ability to track key performance metrics, and our commitment to continuous improvement. Our TAVR team has performed 2150 procedures in the past 9 years and is dedicated to the highest standards of quality and safety. This focus translates to superior clinical outcomes for our patients. Dr. Juan Carlos Plana, Chief of Cardiovascular Services Baylor St. Luke’s Medical Center.
Related Research and Special Issue of the Annals of Cardiovascular Surgery with guest editor Dr. Ourania Prevenza
Annals of Cardiovascular Surgery Vol 10, No 5 (September 2021): Transcatheter Valve-in-Valve
Hemodynamic outcomes after valve-in-valve transcatheter aortic valve replacement: a single-center experience
Transcatheter valve-in-valve implantation for degenerated stentless aortic bioroots
Open transcatheter valve replacement for prosthesis-patient mismatch at redo surgical aortic valve replacement
Texas Heart Institute at Baylor St. Luke’s Medical Center recognized as Houston’s Highest-Ranking Center for Adult Cardiology & Heart Surgery by U.S. News & World Report
Chronicles the Development of the Permanent Artificial Heart
Burgeoning Hybrid Atrial Fibrillation Program at THI Bolstered by FDA Approval of Innovative New EPi-Sense Treatment System
ABOUT TEXAS HEART INSTITUTE (THI)
The Texas Heart Institute, founded by world-renowned cardiovascular surgeon Dr. Denton A. Cooley in 1962, is a nonprofit organization dedicated to reducing the devastating toll of cardiovascular disease through innovative and progressive programs in research, education, and improved patient care. THI’s scientists and physicians conduct fundamental biomedical, translational, and clinical research in cardiology, cardiovascular surgery, molecular-based medicine, stem cell and gene therapy, and regenerative medicine both independently and in collaboration with organizations worldwide. As global leaders of patient care for nearly six decades, Texas Heart Institute has been ranked among the top cardiovascular centers in the United States by U.S. News & World Report for the past 30 years. THI is dedicated to spreading awareness and sharing updates on ways to prevent, treat and defeat cardiovascular disease. With over 10 million visitors coming to its website from around the world every year, www.texasheart.org is just one of the ways THI is helping to educate people on the importance of heart health. For more information, please visit https://www.texasheart.org.